Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$5.1 million.

  • Maravai Lifesciences Holdings' Change in Receivables rose 1498.84% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.3 million, marking a year-over-year increase of 7443.54%. This contributed to the annual value of -$14.4 million for FY2024, which is 8298.6% up from last year.
  • Maravai Lifesciences Holdings' Change in Receivables amounted to -$5.1 million in Q3 2025, which was up 1498.84% from -$501000.0 recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Change in Receivables registered a high of $70.8 million during Q1 2021, and its lowest value of -$82.4 million during Q1 2023.
  • In the last 5 years, Maravai Lifesciences Holdings' Change in Receivables had a median value of -$3.2 million in 2023 and averaged -$1.2 million.
  • Examining YoY changes over the last 5 years, Maravai Lifesciences Holdings' Change in Receivables showed a top increase of 60208.21% in 2021 and a maximum decrease of 988284.88% in 2021.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Change in Receivables stood at $51.5 million in 2021, then crashed by 49.99% to $25.8 million in 2022, then tumbled by 65.92% to $8.8 million in 2023, then soared by 30.11% to $11.4 million in 2024, then crashed by 144.76% to -$5.1 million in 2025.
  • Its Change in Receivables stands at -$5.1 million for Q3 2025, versus -$501000.0 for Q2 2025 and -$10.2 million for Q1 2025.